Advanced Cardiac Risk Panel

Screening · §94

Your annual physical checks cholesterol and calls it "in range." Roughly half of first heart attacks happen in people that panel never flagged. Here's what you didn't know you didn't know: cholesterol mass is a blurry proxy for the thing that actually clogs arteries. The advanced panel adds sharper markers — a particle count, an inherited risk factor set in childhood, an inflammation reading — plus a ten-minute scan that counts the plaque already in your arteries. It doesn't treat anything. It tells you, years earlier, whether the low-risk story your doctor gave you is true.

Screen · Yearly Evidence Moderate Chapter Screening

ApoB counts the bad particles directly instead of weighing the cholesterol inside them. In about one adult in five the two disagree, and when they do it's the particle count that tracks your heart-attack risk ¹. Usually the mismatched ones carry belly weight, high triglycerides, or creeping blood sugar.

Lp(a) is an inherited, sticky form of LDL, set by your genes in childhood and barely moved by diet or exercise. About one adult in five runs high, and most never find out ². It's the most under-diagnosed inherited cardiac risk factor there is ³.

hs-CRP reads system-wide inflammation, the thing that ruptures plaque. People with normal cholesterol but high hs-CRP cut heart attacks and strokes 44% on a statin ⁴.

The calcium scan is the headline. A non-contrast CT counts the plaque sitting in your arteries right now. A score over 300 carries roughly eight times the heart-attack rate of a score of zero ⁵. It's the one line that reads anatomy, and the one most likely to change what you do.

This is a screening decision, not a daily habit. The schedule matters more than the panel.

Costs, if insurance won't pay: ApoB $20–60, Lp(a) $25–75, a full bundle $200–500 a year. The scan runs $75–250 and about 1 mSv of radiation, roughly a mammogram.

Two to three weeks after the draw, a page of numbers most people never see. For a young adult with no family history, nearly all of it sits in the "fine" range, which is the panel confirming a low-risk picture so you can stay conservative.

For about one adult in five, one number rewrites the story: the Lp(a) that explains a father's heart attack at 56, the ApoB higher than the cholesterol let on, the blood sugar quietly creeping for three years. The first month of consequences is small and administrative — a doctor's visit, a statin started at 39 instead of 49, or not started at 52 because the scan said the case was weak.

Most of the payoff is years out and statistical. Right-timed statin therapy cuts first heart attacks by about a third in the right patients ⁶. The exceptions land sooner: a corrected thyroid or a fixed vitamin D deficiency can feel different in weeks. For everyone else, the panel buys decisions, not feelings.

The fine print — when to skip it, and what people get wrong

LDL alone isn't enough for everyone: in one in five adults the particle count runs higher than the cholesterol number, and ApoB reads it directly ⁷. A calcium score of zero means low ten-year risk, not permission to ignore Lp(a) or blood sugar ⁸. Vitamin D pills haven't lowered heart-attack rates in people who aren't deficient ⁹.

Over-reacting to one value is the classic trap: hs-CRP spikes for two weeks after a cold, testosterone peaks in the morning, insulin needs a real ten-hour fast. Repeat an odd reading before acting. The chest CT also finds incidental lung or thyroid nodules that usually mean nothing but can trigger anxious follow-up; pick a centre that reports them conservatively.

References

1Marston et al. (2022). Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis. JAMA Cardiology. link
2Erqou et al. (2009). Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality. JAMA. link
3Kronenberg et al. (2022). Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European Heart Journal. link
4Ridker et al. (2008). Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (JUPITER). New England Journal of Medicine. link
5Detrano et al. (2008). Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups. New England Journal of Medicine. link
6Grundy et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology. link
7Sniderman et al. (2019). Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology. link
8Blaha et al. (2017). Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. link
9Manson et al. (2019). Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (VITAL). New England Journal of Medicine. link

Related in the handbook (8)

Diagnosis

— Very high LDL on this panel can be the first flag for an inherited cholesterol disorder.

— The calculator estimates your risk; this panel refines it when the estimate sits on the fence.
— ApoB and Lp(a) are the heart of this panel — the numbers a standard cholesterol test skips.
— The calcium scan looks at the artery directly; the advanced panel measures the drivers — they're complementary.
— The panel only pays off if you read it right — 'normal' on the lab sheet often isn't optimal for your heart.
— The panel only pays off if you act on it — for high apoB, these are the tools to push it down.
— The signal is free but vague; a blood panel turns it into numbers — the blood pressure, sugar, and cholesterol actually driving it.
— If this panel shows high triglycerides, prescription omega-3 is one of the most reliable ways to bring them down.